2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Lip Cancer
Lip cancer, a subtype of oral cancer, poses a significant health concern globally. Research in this field delves into various aspects, including risk factors, early detection methods, and treatment modalities. Studies highlight the role of tobacco and alcohol consumption as primary risk factors, emphasizing the importance of lifestyle modifications for prevention. Furthermore, advancements in molecular biology have led to the identification of genetic markers associated with lip cancer, aiding in personalized treatment approaches. Early detection techniques such as screening programs and innovative imaging technologies offer promising avenues for timely intervention. Additionally, ongoing research explores novel therapeutic strategies, including targeted drug therapies and immunotherapies, to improve patient outcomes. Collaborative efforts among researchers, healthcare professionals, and policymakers are crucial in advancing lip cancer research and addressing the growing burden of this disease.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China